Rain Is Focus for Grain

U.S. corn and soybean futures ended last week higher, boosted by worries that dry weather in the key growing belt from Iowa to Indiana could hinder crop development, shrinking the harvest this fall.

IPO Drought Hits U.S. After Facebook Debacle

The U.S. has gone three weeks without an initial public offering, the longest drought in about five months.

Telefónica to Sell China Unicom Stake

Telefónica agreed to sell a 4.56% stake in China Unicom to its parent company for about €1.13 billion.

Telefónica to Sell China Unicom Stake

Telefónica agreed to sell a 4.56% stake in China Unicom to its parent company for about €1.13 billion.

Shareholders Press Alcatel-Lucent

Shareholders expressed disappointment about performance at Alcatel-Lucent, putting new pressure on the management to deliver on promises of a turnaround.

Dow Wraps Up Week With a Win

Stocks rallied Friday, extending major benchmarks' biggest weekly gains of the year, as speculation about potential Spanish bailout talks this weekend buoyed sentiment.

U.S. Exports Face Headwinds

U.S. exports declined in April for the first time since November, underscoring that as the global economy weakens and the dollar strengthens, U.S. companies are finding it harder to sell their goods abroad.

China Readings Show Room for Stimulus

Inflation in China slowed significantly in May, while industrial-production growth ticked up less than expected, giving Beijing additional room to loosen policy and stimulate growth.

Studies Show J&J Drug Cuts Blood Sugar

Data from advanced clinical studies of a new type of diabetes drug being developed by a unit of Johnson & Johnson showed it reduced a measure of blood sugar in patients with type 2 diabetes.

Big U.S. Banks Brace for Downgrades

Banks, bond issuers and investors are bracing for aftershocks from a wave of bank downgrades expected to hit the U.S. as soon as the coming week.

Gupta 'Highly Likely' to Testify

Rajat Gupta, accused of tipping hedge-fund manager Raj Rajaratnam with corporate secrets, is likely to take the stand next week in what could be a game-changer for his insider-trading trial.

Sanofi Drug Cuts Blood Sugar More Than Merck's

Sanofi's Lantus insulin reduced blood-sugar levels to a greater degree than Merck's Januvia in people with Type 2 diabetes in a clinical trial.

FDA Approves Roche Breast Cancer Drug

The FDA approved a new drug to treat women with advanced cases of a specific type of breast cancer.Perjeta, was developed by Roche Holding's Genentech unit to treat women whose breast cancer tests positive for protein called HER2 and has spread beyond the breast.

McGraw-Hill Unit Gets New Chief

McGraw-Hill tapped Lloyd Waterhouse, a former IBM executive with experience in education, as the chief of its education arm.

U.S. Trade Gap Narrows

The U.S. trade deficit narrowed in April to $50.06 billion, amid a sharp pullback in imports and exports to the euro zone.

J&J to Book $600 Million Charge

Johnson & Johnson said it plans to set aside an additional $600 million in its second quarter for potential legal settlements.

Gupta 'Highly Likely' to Testify in Trial

Rajat Gupta, accused of tipping hedge-fund manager Raj Rajaratnam with corporate secrets, is likely to take the stand next week in what could be a game-changer for his insider-trading trial.

Apple to Release Tracking Tool for Apps

Apple is planning to release a new way for mobile app developers to track who uses their software, according to people briefed on Apple's plans.

Chesapeake Directors Voted Off the Board

Chesapeake Energy shareholders rebuked the company's management by overwhelmingly voting against the two directors standing for re-election, whotendered their resignations.

U.S. Postpones Changes to Release of Key Data

The Department of Labor said it will postpone planned changes to its release of key data such as the market-moving U.S. jobs report.